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This paper considers the impact of an acute individual's spontaneous 
clearance, recovery of a chronic individual with full immunity, and risk 
factor reduction on a hepatitis B virus (HBV) model. The existence and 
the positivity solution of the model are established. The model 
threshold quantity is defined and sensitivity analysis is analyzed to 
demonstrate the effect of various parameters on the spread of the 
virus. The global stability analysis of the equilibrium is shown using 
Lyapunov and comparison theorem methods. Finally, computational 
simulation is presented to validate the analytical solution. The results 
show that treatment, spontaneous clearance and reduction of the risk 
factor are highly successful in transmitting and regulating HBV 
transmission. The effective measure of these parameters as 
substantiated by our simulations, providing an excellent control 
method of the transmissible infection of HBV.
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Introduction
Hepatitis B is a common liver infection caused by the potentially life-threatening hepatitis B virus (HBV). HBV can
cause a serious infection, which places individuals at high risk of dying from fibrosis and cirrhosis of liver. It is a huge
worldwide health issue. As reporting by the World Health Organization, around 360 million of the 2 billion people
infected with the HBV are reported to have a lifelong chronic infection, and 887,000 of those individuals die from liver
cirrhosis or primary hepatocellular carcinoma (WHO, 2020). As of 2016, 27 million individuals (10.5%) of all people
considered to be living with HBV were aware of their infection, while 4.5 million (16.7%) of those diagnosed were
receiving treatment (WHO, 2019). TheWestern Pacific region recorded the highest incidence rate of HBV at 6.2% of the
adult population, while this was 6.1% in theAfrican region, and 0.7% in the American region on (WHO, 2019). Although
HBV lives outside the body for about seven days, it is still very possible for it to cause an infection if it is injected into an
unvaccinated individual. It takes about 75 days on the average for the HBV to incubate but this can vary between 30 and
180 days. Detection of the virus can be between 30 and 60 days of being infected or consequently mature into full-blown
HBV (CDC, 2019).
The HBV, a hepatotropic non-cytopathic virus, is responsible for the disease (Ribiero, 2002). In highly endemic areas,
perinatal transmission or horizontal transmission (exposure to infected blood) are the primarymeans of transmission (Pan
and Zhang, 2005). The most common method of transmission is from mother to child at birth, particularly from infected
children to uninfected children within the first 5 years of life. Contaminated body fluids such as vaginal discharge, saliva,
menstrual flow, and semen are other means of transmission (Pan and Zhang, 2005). Rarer means of transmission include
transpiration, breast milk, sweat, and urine by percutaneous or mucosal exposure of infected individuals (Mpeshe and
Nyerere, 2019). In particular, unvaccinated men who have sex with men and heterosexual people with several sexual
partners or who have contact with sex workers may experience sexual transmission of HBV (Khan et. al, 2019). In less
than 5% of cases, infections lead to chronic hepatitis in adulthood. Virus transmission can also occur either in health care
facilities or through the reuse of needles and syringes among individuals who inject drugs. Furthermore, infection can
occur during medical, surgical and dental procedures, by tattooing, or by using razors and similar products contaminated
with infected blood (Mpeshe and Nyerere, 2019).
Typically, there is a 5-10% chance of recovery for adults that develop chronic infections (Chenar et al., 2018). Host
variables are believed to be responsible for determining whether the infection is cleared or becomes chronic, especially
immune responses (Ciupe et al., 2007). Different aspects of HBV dynamics and the immune response during infection
have been investigated by several mathematical models (Ribiero, 2002; Long et al., 2008; Lau et al., 2009; Wang et al.,
2010; Qesmi et al., 2010; Pang et al., 2010).
As a result of the research mentioned above, we present an infectious disease model to better understand how testing and
treatment affects HBV transmission dynamics and prevalence. Themodel formulation ofHBV transmission dynamics, as
well as the dynamical behavior of the model, including equilibria and stabilities is presented in this paper. The aim of this
study is to contribute to the development of HBV control strategies and the establishment of intermediate objectives for
intervention programs.
Model formulation
It has been clinically shown that a proportion of HBV acutely infected individuals can spontaneously clear the virus (Pan
and Zhang, 2005). Also, infectious individuals under treatment can become prone to re-infection if they discontinue
treatment, or consume alcohol or use of drugs, which can reduce the impact of the treatment. In view of this, the following
model is developed where the population is divided into different states, namely: the susceptible, the acute, the chronic
carriers, the treated and the recovered states.
At time t, denoted byN tð Þ, the total population is divided into the following five classes/subgroups (Table 1) correspond-
ing to different epidemiological status.
N tð Þ¼ S tð ÞþA tð ÞþC tð ÞþT tð ÞþR tð Þ (1)
where S tð Þ are the susceptible populace, A tð Þ is the populace that are acutely infected with HBV,C tð Þ are the chronically/
clinically infected individuals, while T tð Þ are individuals under treatment and R tð Þ are the recovered classes.
Figure 1 schematically represents the epidemiology of HBV. The various disease stages are replicated by the various
compartments (circle) and the arrows demonstrate theway an individual progress from one state to the other. It is assumed
that at time t, susceptible individual S, enter the population at a constant rate ζ 1αð Þ 1 γCð Þ where ζ is the birth rate,α
is the proportion of population successfully immunized, while γ is the probability that children born to carrier mothers will
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Table 1. Parameter descriptions.
Parameter Description
ζ birth rate
α Proportion of population successfully immunized
γ Probability that children born to carrier mothers will develop to chronic state
λs Horizontal transmission coefficient
ξ Reduced transmission coefficient
η Spontaneous clearance proportion
1=ω Duration of acute phase
k Rate at which treated individuals recover with full immunity
μ Natural death rate
σ Treatment rate for chronic individuals
ν Proportion of population recovering
ρ Duration of HBV treatment






Figure 1. Compartmental flow diagram of hepatitis B virus.
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develop to chronic state. For all classes, individuals die at a constant natural mortality rate, μ: We assume that HBV
infected individuals on treatment are infectious. Susceptible individual S may acquire HBV infection when in contact
with individuals in A,C,and T populace at a rate λs (force of infection associated with HBV), where
λs ¼ βAþ ξ1βCþ ξ2βT (2)
where βA and βC are the effective contact rate for HBV infection to occur/probability that a contact will result in anAcute
and Chronic HBV compartment, respectively. Modification ξ > 1 accounts for a higher risk of HBV acquisition for
people living with Chronic HBV.
A proportion of the acute HBV infected individuals η, becomes chronic carriers and then get treated at σ, while the
remaining proportion 1ηð Þ spontaneously clear the virus. 1ω is the duration of acute phase. A proportion of the
treated HBV individuals, κ, recover with full immunity, some were in the process of recovering in the treated populace at
a rate, υ and duration for the treatment is given as ρ while the remaining proportion 1κð Þ becomes susceptible. Those
individuals in the process of recovering in the treated populace at a rate, υ if engaging/exposed to high-risk habit and those
on treatment ρ can be re-infected at the rate νρ if they discontinue treatment at a rate of ε.
dS
dt












¼ ζαþ kυρT εRμR
where λs ¼ βAþ ξ1βCþ ξ2βT
Model implementation
Positivity and boundedness of solutions
Frommodel (3), we observed that the variables are nonnegative and the solutions are non-negative for all time t ≥ 0: The
parameters used are assumed to be positive and show that the feasible solutions are bounded in the region.
Lemma 1: The initial values of the parameters are
S 0ð Þ≥ 0,A 0ð Þ≥ 0,C 0ð Þ≥ 0,T 0ð Þ≥ 0,R 0ð Þ≥ ,0 and N 0ð Þ≥ 0f g∈Φ
Then the solution of the model S tð Þ,A tð Þ,C tð Þ,T tð Þ,R tð Þ,N tð Þf g is positive for all t ≥ 0:
Proof: Considering the first equation in (3),
dS
dt











S≥ S0e λsþμð Þ ≥ 0
Hence, S≥ 0
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A≥ A0e ωþμð Þ ≥ 0
Hence, A≥ 0
The same approach applies to the proof of the positivity of C, T and R.
Equilibrium points and reproduction number
The disease-free equilibrium of the model (3) exists and is given by:
Eoð Þ¼ ζ 1αð Þμ ,0,0,0,0
 
(4)
The endemic steady state of the model (3) exists and is presented as follows:
S∗ ¼ μþωð Þ ζ γ μþρð Þ α1ð Þρσνþμ























L¼ μðΛηkωρσυþΛζαεγμþΛζαεγρþΛζαγμ2þΛζαγμρþ ζαεγμ2þ ζαεγμωþ ζαεγμρþ ζαγμ3þ ζαγμ2ω
þ ζαγμ2ρþ ζαγμωρΛζ εγμΛζεγρΛζγμ2ΛζγμρþΛεημωþΛεηωρþΛεηωσþΛερσυ
þΛημ2ωΛημωρþΛημωσþΛμρσυ ζεγμ2 ζ εγμω ζ εγμρ ζγμ3 ζγμ2ω ζγμ2ρ ζ γμωρ
þ εμρσυþ εωρσυþμ2ρσυþμωρσυþΛεμ2þΛεμρþΛεμσþΛμ3þΛμ2ρþΛμ2σ
þ εμ3þ εμ2ρþ εμ2σþ εμωρþ εμωσþμ4þμ3ωþμ3ρþμ3σþμ2ωρþμ2ωσ
H¼ α2α γμ3þ Λþωþρð Þα2þ Λωρð ÞαÞγμ2þ Λρþωρð Þα2þ Λρωρð ÞαÞγμÞζ 2
þ αμ4þ ρþωþσþΛð Þαμ3þ σνþΛþωð Þρþ ηωþσð ÞΛþωσð Þαμ2þ ηωþσνð ÞΛþωσνð ÞρþΛηωσ αμ
þΛηkωρσνÞζ
By using the next generation matrix, the basic reproduction number is determined and given by:
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ωþμð Þ ζαγμþ ζαγρ ζ γμ ζ γρþρσυρσð Þ
ρþμð Þ
ζαγμþ ζαγρ ζ γμ ζ γρþρσυρσð Þ
1 νð Þρ
ζαγμþ ζαγρ ζ γμ ζ γρþρσυρσð Þ
ηωσ
ωþμð Þ ζαγμþ ζαγρ ζ γμ ζ γρþρσυρσð Þ
σ
ζαγμþ ζαγρ ζ γμ ζ γρþρσυρσð Þ
ζαγþ ζ γþμþρ





The reproduction number is given by ρ(FV1), and
R0¼ βζ 1αð Þ
μ ωþμð Þ þ
βζ 1αð Þηω μξ1þρξ1þσξ2ð Þ
μ ωþμð Þ ζαγμþ ζαγρ ζ γμ ζ γρþρσυρσð Þ (10)
Global stability of the equilibria
The global stability of the disease-free equilibrium was investigated using the Comparison method at the disease - free
equilibrium Eo. Theorem 1 proves the global stability of disease -free equilibrium Eo
Theorem 1: The disease - free equilibrium Eo of system (3) is globally asymptotically stable if Ro < 1 and unstable if Ro > 1.
Proof: The Comparison method as implemented in Lashmkantham, et al (1989) and Mushayabasa et al (2011) is used































































Page 6 of 14
F1000Research 2021, 10:429 Last updated: 28 MAY 2021
Then all eigenvalues of the matrix FVð Þ have negative real parts, i.e
βζ 1αð Þ
μ




ηω ζ 1αð Þγþσþμ λ 0












ηωξ1βζα ζ 1αð Þγζ αβηωξ1βζ þ ζ 1αð Þγβζ 2ζ 1αð Þγμ2 ζ 1αð Þγμω ζ 1αð Þγμρþ2ζαβμ





ζαβρμþ ζαβμσþ ζαβρσþ ζ 1αð Þγβζμþ ζ 1αð Þγβζ ρ ζ 1αð Þγμωρημωξ1βζ ηωξ1βζρ
 ζ 1αð Þγζαβμ ζ 1αð Þγζ αβρþμ4βζμ2þμ2ωρþμ2ωσþμ2ρσ ζ 1αð Þγμ3þμ3ωþμ3ρþμ3σ







Equation (11) has three negative roots by Descartes rule of signs if
1
μ
ζαβρμþ ζαβμσþ ζαβρσþ ζ 1αð Þγβζμþ ζ 1αð Þγβζ ρ ζ 1αð Þγμωρημωξ1βζ ηωξ1βζρ
 ζ 1αð Þγζαβμ ζ 1αð Þγζ αβρþμ4βζμ2þμ2ωρþμ2ωσþμ2ρσ ζ 1αð Þγμ3þμ3ωþμ3ρþμ3σ







ηωξ1βζα ζ 1αð Þγζ αβηωξ1βζ þ ζ 1αð Þγβζ 2ζ 1αð Þγμ2 ζ 1αð Þγμω ζ 1αð Þγμρþ2ζαβμ
þ ζαβρþ ζαβσ 2ζ βμ ζ βρ ζ βσþ3μ3þ2μ2ωþ2μ2ρþ2μ2σþμωρþμωσþμρσ
 !







ζαβρμþ ζαβμσþ ζαβρσþ ζ 1αð Þγβζμþ ζ 1αð Þγβζ ρ ζ 1αð Þγμωρημωξ1βζ ηωξ1βζρ
 ζ 1αð Þγζ αβμ ζ 1αð Þγζ αβρþμ4βζμ2þμ2ωρþμ2ωσþμ2ρσ ζ 1αð Þγμ3þμ3ωþμ3ρþμ3σ
þ ζαβμ2 ζ βρμ ζ βμσ ζ βρσþμωρσ ζ 1αð Þγμ2ω ζ 1αð Þγμ2ρηωξ2βζσþαηωξ2βζσ
þηωξ1βζαμþηωμρξ1βζ
ηωξ1βζα ζ 1αð Þγζαβηωξ1βζ þ ζ 1αð Þγβζ 2ζ 1αð Þγμ2 ζ 1αð Þγμω ζ 1αð Þγμρþ2ζαβμ
þ ζαβρþ ζαβσ 2ζβμ ζ βρ ζβσþ3μ3þ2μ2ωþ2μ2ρþ2μ2σþμωρþμωσþμρσ
 !
βζα ζ 1αð Þγμβζ þ3μ2þωμþρμþσμ 
< 1
∴ R0 < 1:
It follows that the linearized differential inequality is stable whenever R0 < 1. Consequently, A,C,Tð Þ! 0,0,0ð Þ as
t!∞. Evaluating system (3) at A¼C¼ T ¼ 0 gives S! 1for R0 < 1. Hence, the disease-free equilibrium E0 of system
(3) is globally asymptotically stable if R0 < 1. The result also follows immediately that the disease-free equilibrium E0 of
system (3) is unstable if R0 > 1.
Theorem 2: The equations of the model has a positive distinctive endemic equilibrium whenever R0 > 1, which is said to
be globally asymptotically stable.
Proof: Considering the Lyapunov function defined as:
L S∗,A∗,C∗,T∗,R∗ð Þ¼ SS∗ ln S
S∗
  
þ AA∗ ln A
A∗
  
þ CC∗ ln C
C∗
  
þ TT∗ ln T
T∗
  
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ζαþ kυρT εþμð ÞR½  (14)
At equilibrium,
ζ 1αð Þ 1 γCð Þ¼ βA∗þ ξ1βC∗þ ξ2βT∗ð ÞS∗ 1ηð ÞωA∗þμS∗ 1 kð ÞνρT∗ εR∗
ωþμð Þ¼ βA
∗þ ξ1βC∗þ ξ2βT∗ð ÞS∗
A∗


















βA∗þ ξ1βC∗þξ2βT∗ð ÞS∗ 1ηð ÞωA∗þμS∗ 1 kð ÞνρT∗ εR∗






βAþ ξ1βCþ ξ2βTð ÞS































βA∗S∗þ ξ1βC∗S∗þ ξ2βT∗S∗ 1ηð ÞωA∗þμS∗ 1 kð ÞνρT∗
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þP1 S,A,C,T ,Rð ÞþP2 S,A,C,T ,Rð Þ
where,


































































































AS≥ A∗S∗,CS≥C∗S∗,TS≥ T∗S∗ (19)
and
P2≤0 whenever
A∗S≥ A∗S∗,A∗CS≥ AC∗S∗,TSA∗ ≥ T∗S∗A,ATC∗ ≥ A∗T∗C,CT∗ ≥ C∗T ,TR∗ ≥ T∗R (20)
Thus,
dL
dt ≤ 0 if the condition in (19) and (20) holds.
Therefore, by LaSalle asymptotic stability theorem (LaSalle, 1976), and Adeniyi et al. (2020), the positive equilibrium




To test the strength of the model and the parameter values, a sensitivity study was carried out. This is done in order know
the parameters that have a huge influence on the basic reproduction number (R0) which is done usingMaple 19 software.







TheR0 sensitivity is therefore derived from each of the different parameters listed in Table 1. All expressions are complex
for sensitivity indices, so sensitivity indices are evaluated in Table 2 at the baseline parameter values.
Model validation
To validate our analytical results, we perform numerical simulations of the proposed model (2). These simulations are
based on qualitative analysis. Some of the parameters were obtained from published research, while others were estimated
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by the authors as they were thought to be biologically feasible. We employ a strictly numerical RK (Runge-Kutta)
technique of order four embedded in the Maple 19 software. Table 3 contains the parameter's comprehensive values.
Considering the first sizes of compartmental population, taking the parameter values and the interval (0-60) using
the linear stability analysis, we perform the simulations and obtain the outcomes shown in Figure 2. The dynamic
behavior of susceptible individuals is represented in Figure 2A, showing the existence of the susceptible individuals. It
was discovered from Figure 2B that the acute populace decreases with the passage of time. Ditto the behaviors of chronic,
treated and recovered populace, respectively, are dynamically represented in Figure 2C, D and E. The trajectories S(t),
A(t), C(t), T(t), and R(t) distinctly converge to the disease-free equilibrium of E0 = (S_0, 0, 0, 0, 0, R_0) = (1.678018396,
0, 0, 0, 0, 0, 0, 0.06801334973) as indicated in Eq. (10), when R0 = 0.07150316516< 1. The dynamics of the susceptible
populace with respect to the treatment rate σ, recovering rate with full immunity k and the rate at which recovered
individual fallout from risk reduction ϵ is shown in Figure 3A. It is evident from Figure 3A that with the increase in the
parametric values, the susceptible population increases, even as increase is not evident due to those who recover with
complete immunity. However, there is still an increase due to some people who fall out of risk reduction, checking the
cumulative impact of the parameters causing the increment of the susceptible populations. The inverse relationship of the
compartmental population (acute and chronic) with the variance of the above parameters is shown in Figure 3B and C.
Thismeans that it is possible tominimize acute and chronic individuals by increasing the parametric values. The variation












Table 3. Parameter values used for the numerical simulation.
Parameter Values Source
ζ 0.012100 Khan et al (2019)
β 0.009500 Khan et al (2019)
ξ 0.160000 Khan et al (2019)
ϵ 0.050000 Estimated
η 0.067000 Estimated
γ 0.110000 Khan et al (2019)
σ 0.590000 Khan et al (2019)
α 0.320000 Khan et al (2019)




υ 0.05000 Khan et al (2019)
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of the treated and recovered populace is shown in Figure 3D and E. An increase in the treated and the recovered
population is caused by increasing the values of the parameters. It can be clearly inferred from our computational
simulations that treatment, spontaneous clearance and reduction of the risk factor are highly successful in transmitting
and regulating HBV transmission. The effective measure of these parameters as substantiated by the simulations is an
excellent control method of the transmissible infection of HBV.
Figure 2. The dynamical behavior of the varying population of the classes: (A) susceptible (B) acute (C) chronic
(D) treated (E) recovered using the Maple 19 software.
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Conclusion
A deterministic model of hepatitis B that involves the spontaneous clearance of an acute individual and also recovery
of chronic individual with full immunity and risk factor reduction was developed and investigated. Disease-free and
endemic equilibria of the model exist. The basic reproduction number was constructed by the method of next generation
matrix. The global stability of the disease-free and endemic equilibria was discussed and shown to be asymptotically
stable. The effects of the treatment rate, the recovery rate with complete immunity, and the risk mitigation factor were
thoroughly discussed. Future work may include using the optimum control theory to mitigate hepatitis B infection.
Figure 3. The dynamical behavior of the various classes varying various treatment parameter (A) susceptible
(B) acute (C) chronic (D) treated (E) recovered using the Maple 19 software.
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Data availability
All data underlying the results are available as part of the article and no additional source data are required.
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